The United States Pharmacopeia today notified stakeholders that it is postponing the official effective dates of several new and revised standards pertaining to pharmaceutical handling until further notice while it reviews appeals to the standards. Those standards include general chapters <795> (Pharmaceutical Compounding – Nonsterile Preparations), <797> (Pharmaceutical Compounding – Sterile Preparations), and <825> (Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging). In addition, due to the pending appeals, USP new general chapter <800> (Hazardous Drugs Handling in Healthcare Settings) will remain official, but only informational and will not be applicable until the appeals process is complete. The AHA in November 2018 urged USP to delay the official dates of both USP <797> and <800> due to expedited implementation and compliance concerns.

Related News Articles

Headline
The Agency for Healthcare Research and Quality seeks comments through July 1 to inform development of a potential Consumer Assessment of Healthcare…
Headline
Health care providers should not use non-invasive prenatal screening tests alone to diagnose genetic abnormalities due to the potential for false results…
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until April 6 to access updated provider preview reports of their quality data. The…
Headline
Robyn Begley, chief nursing officer for the AHA and CEO of the American Organization for Nursing Leadership, today issued a statement in response to a decision…
Chairperson's File
One week in early March every year is designated as Patient Safety Awareness Week, a national recognition to encourage everyone to learn more about health care…
Headline
To support National Patient Safety Awareness Week, which starts Sunday, the American Society for Health Care Risk Management has developed free tip sheets and…